Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
not_yet_recruiting125%
unknown250%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Effects of Maqui Supplementation on Gut Microbiota, Inflammation, and Oxidative Stress in Patients With Chronic Kidney Disease

NCT07776925
recruitingnot_applicable

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

NCT07350694
unknownnot_applicable

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

NCT03377829
unknown

Lactated Ringer's and PlasmaLyte in Critically Ill Adults

NCT03813563

Clinical Trials (4)

Showing 4 of 4 trials
NCT07776925Not Applicable

Effects of Maqui Supplementation on Gut Microbiota, Inflammation, and Oxidative Stress in Patients With Chronic Kidney Disease

Not Yet Recruiting
NCT07350694Not Applicable

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

Recruiting
NCT03377829Not Applicable

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

Unknown
NCT03813563

Lactated Ringer's and PlasmaLyte in Critically Ill Adults

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4